Slide 1: Cochlear Limited 2012 Annual General Meeting
For personal use only JODI ALLION (mother) LEAH Miami, USA Cochlear Limited 2012 Annual General Meeting Exchange Square Auditorium Australian Securities Exchange 20 Bridge Street Sydney NSW 2000 Tuesday 16th October 2012 1
Slide 2: Chairman and Company Secretary
Mr Rick Holliday-Smith – Chairman For personal use only Mr Neville Mitchell – Company Secretary 2
Slide 3: CEO and Director
Dr Chris Roberts – Chief Executive Officer / President For personal use only Prof Ed Byrne AO – Director 3
Slide 4: Directors
Mrs Yasmin Allen – Director For personal use only Mr Paul Bell – Director 4
Slide 5: Directors
Mr Donal O’Dwyer – Director For personal use only Mr Andy Denver – Director 5
Slide 6: Chairman's Address
For personal use only Chairman’s Address Rick Holliday-Smith 6
Slide 7: CEO's Address
For personal use only CEO’s Address Chris Roberts 7
Slide 8: The Journey Continues… Cochlear Overview
The Journey Continues… For personal use only Cochlear Overview • Cochlear Limited (ASX:COH) is the global leader in implantable devices (e.g. cochlear implants) for the hearing impaired • ~ 2,500 employees • Direct operations in 20+ countries, and products sold in 100+ countries • Fundamentals of th
Slide 9: F12: A Review
F12: A Review For personal use only • Unimplanted CI500 series implants Cochlear Sound Remote Programming Software. Implant Processor Assistant recalled Sep 2011 with significant Custom Sound™ financial expense ($138.8 million pre-tax provision) However • Implant component of Nucleus cochlear implan
Slide 10: Cochlear F12
Cochlear F12 For personal use only Sales CI Unit Sales BAS Sales $704.6 million 23,087 units $77.9 million Up 1% in Down 6% Down 4% in constant currency (CC) constant currency (CC) Cochlear F12 Earnings Before Interest Net Profit After Tax Dividends Per Share & Tax (EBIT) (NPAT) (DPS) $76.5 million
Slide 11: Cochlear F12 and Regional Sales
Cochlear F12 For personal use only Earnings Before Interest Net Profit After Tax Dividends Per Share & Tax (EBIT) (NPAT) (DPS) $76.5 million $56.8 million $2.45 Down 68% Down 68% Up 9% * * * Excluding * Excluding product recall product recall expenses expenses Regional Sales in Constant Currency (CC
Slide 12: Product Innovation
Product Innovation For personal use only Nucleus CI422 Implant Nucleus 5 Baha BIA400 Sound Processor Hydroxyapatite coating CR120 Intraoperative Remote Assistant Fitting Codacs Remote Assistant Age Demographics of New Cochlear Implant Recipients in Developed Countries 12
Slide 13: Active and Healthy Ageing
Active and Healthy Ageing For personal use only Use it or lose it • Maintaining hearing is integral to healthy ageing • Hearing loss is an independent risk factor for cognitive decline • In developed markets, cochlear implantation in the over 65s is the fasting growing demographic Bilateral Implants
Slide 14: Hear now. And always
changing Hear now. And aby 14
Slide 15: Business of the Meeting: Resolution 1
Cochlear Limited For personal use only 2012 Annual General Meeting Business of the Meeting Resolution No. 1 Financial and other reports To receive and consider the Company’s Financial Report, Directors’ Report and Auditor’s Report in respect of the financial year ended 30 June 2012 and to consider a
Slide 16: Resolution 1 Proxy Summary; Resolution 2
Resolution No. 1 For personal use only Financial and Other Reports Proxy Summary • Total number of proxy and direct votes cast 34,950,570 100.00% • Votes in favour of the resolution 34,522,558 98.78% • Votes to be cast at the discretion of the proxy 402,498 1.15% • Votes against the resolution 25,51
Slide 17: Remuneration Report Proxy Summary; Resolution 3
Resolution No. 2 For personal use only Remuneration Report Proxy Summary • Total number of proxy and direct votes cast 34,895,367 100.00% • Votes in favour of the resolution 23,992,104 68.75% • Votes to be cast at the discretion of the proxy 339,898 0.98% • Votes against the resolution 10,563,365 30
Slide 18: Resolution 3.1 Re-election of Directors
Resolution No. 3.1 For personal use only Re-election of directors 3.1 “THAT Prof Edward Byrne AO, being a director who is retiring by rotation in accordance with the Company’s Constitution and who, being eligible, offers himself for re-election as a director of the Company, be re-elected as a direct
Slide 19: Resolution 3.2 Re-election of Directors
Resolution No. 3 For personal use only Re-election and election of directors To consider and, if thought fit, to pass the following resolution as an ordinary resolution: Resolution No. 3.2 Re-election of directors 3.1 “THAT Mr Andrew Denver, being a director who is retiring by rotation in accordance
Slide 20: Resolution 3.2 Proxy Summary; Resolution 4
Resolution No. 3.2 For personal use only Re-election of directors – Mr Andrew Denver Proxy Summary • Total number of proxy and direct votes cast 35,081,823 100.00% • Votes in favour of the resolution 34,316,999 97.82% • Votes to be cast at the discretion of the proxy 403,940 1.15% • Votes against th
Slide 21: Resolution 4 Proxy Summary; Resolution 5
Resolution No. 4 For personal use only Approval of issue, allocation or transfer of securities to the CEO/President under the Cochlear Executive Long Term Incentive Plan (“CELTIP”) Proxy Summary • Total number of proxy and direct votes cast 34,792,546 100.00% • Votes in favour of the resolution 23,3
Slide 22: Proportional Takeover Provisions Proxy Summary
Resolution No. 5 For personal use only Renewal of Proportional Takeover Provisions Proxy Summary • Total number of proxy and direct votes cast 35,070,131 100.00% • Votes in favour of the resolution 33,384,762 95.19% • Votes to be cast at the discretion of the proxy 406,042 1.16% • Votes against the
Slide 23: Close of Meeting
For personal use only Close of Meeting 23
Slide 24: For personal use only
For personal use only 24